|Chemical and physical data|
|Molar mass||375.468 g·mol−1|
|3D model (JSmol)|
4'-Hydroxynorendoxifen is a synthetic, nonsteroidal antiestrogen of the triphenylethylene group. It is a dual selective estrogen receptor modulator (SERM) and aromatase inhibitor (AI), and was derived from tamoxifen, a SERM, and norendoxifen, a metabolite of tamoxifen that has been found to act as an AI. The drug has been suggested for potential development as a treatment for estrogen receptor (ER)-positive breast cancer. It was synthesized in 2015.
|This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.|